Top Stocks Under $10

Primed to grow right now with long-term potential gains of 2X and more.

Primed to grow right now with long-term potential gains of 2X and more.

PFP 6/5: We're All On the NVIDIA Train

As long as the NVIDIA story is a good one, look for the big-cap indexes to continue to ride the AI wave.

As long as the NVIDIA story is a good one, look for the big-cap indexes to continue to ride the AI wave.

This Week's Top Aggressive Growth Stocks

Zacks Aggrerssive Growth Strategist Brian Bolan has two more stocks for your Aggressive Growth radar screen. In this week's edition, Brian is going to the dogs... but not literally, of course.

Zacks Aggrerssive Growth Strategist Brian Bolan has two more stocks for your Aggressive Growth radar screen. In this week's edition, Brian is going to the dogs... but not literally, of course.

Brian's Big Idea on Bitcoin

With BTC surging back over $70,000 interest has returned to the space.

With BTC surging back over $70,000 interest has returned to the space.

JOLTS Drops to Lowest Levels in 3+ Years

Private-sector payrolls from ADP are out tomorrow ahead of the bell, as Jobs Week continues.

Private-sector payrolls from ADP are out tomorrow ahead of the bell, as Jobs Week continues.

4 Factors That Drive Share Outperformance

All investors look to reap outsized gains, precisely what these particular stocks we have chosen have provided. But what factors have been aiding the moves?

All investors look to reap outsized gains, precisely what these particular stocks we have chosen have provided. But what factors have been aiding the moves?

Health Care Stocks Show Relative Strength as S&P 500 Stalls

Several stocks are breaking out and trading near all-time highs.

Several stocks are breaking out and trading near all-time highs.

ETFs to Profit from the Weight Loss Drug Boom

According to Goldman Sachs, the market for these drugs could surge to $130 billion by 2030, with Eli Lilly and Novo Nordisk retaining about 80% of the market share.

According to Goldman Sachs, the market for these drugs could surge to $130 billion by 2030, with Eli Lilly and Novo Nordisk retaining about 80% of the market share.

Top Analyst Reports for Roche, Wells Fargo & GE Aerospace

Today's Research Daily features new research reports on 16 major stocks, including Roche Holding AG (RHHBY), Wells Fargo & Co. (WFC) and GE Aerospace (GE), as well as a micro-cap stock Key Tronic Corp. (KTCC).

Today's Research Daily features new research reports on 16 major stocks, including Roche Holding AG (RHHBY), Wells Fargo & Co. (WFC) and GE Aerospace (GE), as well as a micro-cap stock Key Tronic Corp. (KTCC).